Sysmex Corporation ADR (OTCMKTS:SSMXY) Short Interest Update

Key Points

• Sysmex Corporation ADR experienced a dramatic increase in short interest, rising by 225.7% from 28,000 shares to 91,200 shares in July.
• The company's stock price has shown a modest increase of 1.2%, opening at $16.52, with a 1-year trading range of $14.38 to $22.00.
• In its latest quarterly earnings, Sysmex reported an EPS of $0.12, missing expectations of $0.16 and reporting revenue of $958.89 million against an anticipated $991.22 million.

Sysmex Corporation ADR (OTCMKTS:SSMXY - Get Free Report) saw a large increase in short interest in the month of July. As of July 15th, there was short interest totaling 91,200 shares, anincreaseof225.7% from the June 30th total of 28,000 shares. Based on an average daily volume of 143,300 shares, the short-interest ratio is presently 0.6 days. Based on an average daily volume of 143,300 shares, the short-interest ratio is presently 0.6 days.

Sysmex Stock Up 1.2%

Shares of OTCMKTS:SSMXY opened at $16.52 on Monday. Sysmex has a 1 year low of $14.38 and a 1 year high of $22.00. The company has a market cap of $10.40 billion, a PE ratio of 29.50 and a beta of 1.15. The company has a debt-to-equity ratio of 0.12, a current ratio of 2.97 and a quick ratio of 2.30. The stock's 50-day moving average is $16.83 and its 200 day moving average is $17.87.

Sysmex (OTCMKTS:SSMXY - Get Free Report) last announced its quarterly earnings results on Wednesday, May 14th. The company reported $0.12 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.16 by ($0.04). Sysmex had a net margin of 10.56% and a return on equity of 11.81%. The business had revenue of $958.89 million for the quarter, compared to analysts' expectations of $991.22 million. Sell-side analysts anticipate that Sysmex will post 0.57 EPS for the current year.

About Sysmex

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.